Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Merck Other Long-Term Assets 2010-2025 | MKKGY

Merck other long-term assets from 2010 to 2025. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • Merck other long-term assets for the quarter ending March 31, 2025 were $0.113B, a 24.76% decline year-over-year.
  • Merck other long-term assets for 2024 were $0.145B, a 16.5% increase from 2023.
  • Merck other long-term assets for 2023 were $0.124B, a 19.33% increase from 2022.
  • Merck other long-term assets for 2022 were $0.104B, a 7.2% decline from 2021.
  
Merck Annual Other Long-Term Assets
(Millions of US $)
2024 $145
2023 $124
2022 $104
2021 $112
2020 $939
2019 $109
2018 $163
2017 $232
2016 $145
2015 $142
2014 $75
2013 $140
2012 $97
2011 $160
2010 $0
2009 $0
Merck Quarterly Other Long-Term Assets
(Millions of US $)
2025-03-31 $113
2024-12-31 $145
2024-09-30 $141
2024-06-30 $144
2024-03-31 $150
2023-12-31 $124
2023-09-30 $104
2023-06-30 $96
2023-03-31 $107
2022-12-31 $104
2022-09-30 $105
2022-06-30 $105
2022-03-31 $118
2021-12-31 $112
2021-09-30 $100
2021-06-30 $105
2021-03-31 $102
2020-12-31 $939
2020-09-30 $767
2020-06-30 $99
2020-03-31 $104
2019-12-31 $109
2019-09-30 $99
2019-06-30 $99
2019-03-31 $92
2018-12-31 $163
2018-09-30 $177
2018-06-30 $187
2018-03-31 $243
2017-12-31 $232
2017-09-30 $165
2017-06-30 $154
2017-03-31 $135
2016-12-31 $145
2016-09-30 $141
2016-06-30 $142
2016-03-31 $150
2015-12-31 $142
2015-09-30 $70
2015-06-30 $60
2015-03-31 $65
2014-12-31 $75
2014-09-30 $95
2014-06-30 $106
2014-03-31 $126
2013-12-31 $140
2013-09-30 $126
2013-06-30 $108
2013-03-31 $91
2012-12-31 $97
2012-09-30 $200
2012-06-30 $153
2012-03-31
2011-12-31 $160
2011-09-30
2011-06-30 $612
2011-03-31
2010-12-31
2010-09-30 $605
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $16.743B $22.569B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $76.846B 28.83
Zoetis (ZTS) United States $66.795B 24.92
Takeda Pharmaceutical (TAK) Japan $46.902B 9.33
Daiichi Sankyo, - (DSNKY) Japan $45.540B 23.34
BeOne Medicines - (ONC) Cayman Islands $31.822B 0.00
Sandoz Group AG (SDZNY) Switzerland $24.640B 0.00
Summit Therapeutics (SMMT) United States $20.520B 0.00
Shionogi (SGIOY) Japan $14.360B 14.39
United Therapeutics (UTHR) United States $13.412B 11.86
Neurocrine Biosciences (NBIX) United States $13.272B 45.46
Orion OYJ (ORINY) Finland $10.973B 29.68
IPSEN (IPSEY) France $10.477B 0.00
Corcept Therapeutics (CORT) United States $7.752B 63.02
Madrigal Pharmaceuticals (MDGL) United States $7.743B 0.00
Stevanato Group S.p.A (STVN) Italy $7.719B 47.20
Grifols, S.A (GRFS) Spain $6.910B 0.00
Ionis Pharmaceuticals (IONS) United States $6.712B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.214B 15.86
Soleno Therapeutics (SLNO) United States $4.417B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.092B 0.00
Hypermarcas (HYPMY) Brazil $2.939B 19.33
Catalyst Pharmaceuticals (CPRX) United States $2.616B 9.17
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.583B 13.97
NewAmsterdam Pharma (NAMS) Netherlands $2.468B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.132B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.820B 0.00
Ocular Therapeutix (OCUL) United States $1.813B 0.00
ARS Pharmaceuticals (SPRY) United States $1.802B 0.00
Endo (NDOI) United States $1.622B 0.00
Evotec AG (EVO) Germany $1.506B 0.00
Harrow (HROW) United States $1.326B 0.00
Guardian Pharmacy Services (GRDN) United States $1.317B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.225B 24.51
Enliven Therapeutics (ELVN) United States $1.145B 0.00
Ardelyx (ARDX) United States $1.081B 0.00
Dyne Therapeutics (DYN) United States $1.068B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.049B 0.00
Collegium Pharmaceutical (COLL) United States $1.037B 5.59
ProKidney (PROK) United States $1.030B 0.00
Akebia Therapeutics (AKBA) United States $1.019B 0.00
Verve Therapeutics (VERV) United States $0.976B 0.00
Xeris Biopharma Holdings (XERS) United States $0.818B 0.00
KalVista Pharmaceuticals (KALV) United States $0.800B 0.00
Cronos Group (CRON) Canada $0.791B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.738B 0.00
Zevra Therapeutics (ZVRA) United States $0.692B 0.00
Xencor (XNCR) United States $0.646B 0.00
Relay Therapeutics (RLAY) United States $0.626B 0.00
Elite Pharmaceuticals (ELTP) United States $0.609B 0.00
Theravance Biopharma (TBPH) United States $0.581B 0.00
Oruka Therapeutics (ORKA) United States $0.575B 0.00
USANA Health Sciences (USNA) United States $0.570B 12.40
Organogenesis (ORGO) United States $0.553B 0.00
Bioventus (BVS) United States $0.533B 13.52
Siga Technologies (SIGA) United States $0.479B 10.00
Tourmaline Bio (TRML) United States $0.478B 0.00
Aquestive Therapeutics (AQST) United States $0.434B 0.00
Savara (SVRA) United States $0.404B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.347B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.338B 9.14
Nektar Therapeutics (NKTR) United States $0.331B 0.00
Altimmune (ALT) United States $0.328B 0.00
Heron Therapeutics (HRTX) United States $0.305B 0.00
AleAnna (ANNA) United States $0.301B 0.00
Aldeyra Therapeutics (ALDX) United States $0.301B 0.00
Nature's Sunshine Products (NATR) United States $0.271B 24.88
Nanobiotix S.A (NBTX) France $0.250B 0.00
Esperion Therapeutics (ESPR) United States $0.246B 0.00
OmniAb (OABI) United States $0.239B 0.00
MediWound (MDWD) Israel $0.217B 0.00
Larimar Therapeutics (LRMR) United States $0.213B 0.00
4D Molecular Therapeutics (FDMT) United States $0.202B 0.00
China SXT Pharmaceuticals (SXTC) China $0.196B 0.00
Galectin Therapeutics (GALT) United States $0.183B 0.00
Aclaris Therapeutics (ACRS) United States $0.172B 0.00
Profound Medical (PROF) Canada $0.171B 0.00
Journey Medical (DERM) United States $0.170B 0.00
Avita Medical (RCEL) United States $0.144B 0.00
Liminatus Pharma (LIMN) United States $0.142B 0.00
Lexeo Therapeutics (LXEO) United States $0.141B 0.00
Inhibikase Therapeutics (IKT) United States $0.141B 0.00
Lyell Immunopharma (LYEL) United States $0.141B 0.00
Korro Bio (KRRO) United States $0.130B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.128B 0.00
Protara Therapeutics (TARA) United States $0.121B 0.00
Champions Oncology (CSBR) United States $0.116B 19.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.104B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
Cardiol Therapeutics (CRDL) Canada $0.098B 0.00
Achieve Life Sciences (ACHV) Canada $0.095B 0.00
Vivani Medical (VANI) United States $0.094B 0.00
VAXART, INC (VXRT) United States $0.093B 0.00
Fractyl Health (GUTS) United States $0.088B 0.00
Nutriband (NTRB) United States $0.087B 0.00
Arch Biopartners (ACHFF) Canada $0.083B 0.00
ESSA Pharma (EPIX) Canada $0.083B 0.00
Dominari Holdings (DOMH) United States $0.082B 0.00
Context Therapeutics (CNTX) United States $0.082B 0.00
Rafael Holdings (RFL) United States $0.080B 0.00
Metagenomi (MGX) United States $0.080B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.079B 0.00
Surrozen (SRZN) United States $0.073B 0.00
Pyxis Oncology (PYXS) United States $0.072B 0.00
PMV Pharmaceuticals (PMVP) United States $0.069B 0.00
Wellgistics Health (WGRX) United States $0.066B 0.00
Assertio Holdings (ASRT) United States $0.064B 0.00
Klotho Neurosciences (KLTO) United States $0.063B 0.00
Avalo Therapeutics (AVTX) United States $0.061B 0.00
Inotiv (NOTV) United States $0.061B 0.00
Unicycive Therapeutics (UNCY) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Jupiter Neurosciences (JUNS) United States $0.057B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.056B 41.22
ElectroCore (ECOR) United States $0.055B 0.00
NRx Pharmaceuticals (NRXP) United States $0.052B 0.00
Century Therapeutics (IPSC) United States $0.050B 0.00
Gain Therapeutics (GANX) United States $0.048B 0.00
Prelude Therapeutics (PRLD) United States $0.046B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
Acrivon Therapeutics (ACRV) United States $0.041B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
PolyPid (PYPD) Israel $0.039B 0.00
Telomir Pharmaceuticals (TELO) United States $0.036B 0.00
Karyopharm Therapeutics (KPTI) United States $0.035B 0.00
Vivos Therapeutics (VVOS) United States $0.034B 0.00
FibroGen (FGEN) United States $0.033B 0.00
SCYNEXIS (SCYX) United States $0.029B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
Scienture Holdings (SCNX) United States $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.022B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
BioLineRx (BLRX) Israel $0.020B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
Plus Therapeutics (PSTV) United States $0.020B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.019B 0.00
VYNE Therapeutics (VYNE) United States $0.018B 0.00
Citius Pharmaceuticals (CTXR) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.017B 0.00
DURECT (DRRX) United States $0.016B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
ProPhase Labs (PRPH) United States $0.016B 0.00
Ernexa Therapeutics (ERNA) United States $0.015B 0.00
BioVie (BIVI) United States $0.015B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Minerva Neurosciences (NERV) United States $0.014B 2.43
TherapeuticsMD (TXMD) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
Ainos (AIMD) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
Incannex Healthcare (IXHL) Australia $0.011B 0.00
Aptorum Group (APM) United Kingdom $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Redhill Biopharma (RDHL) Israel $0.006B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 9.45
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00